Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1310.3000 -4.50 (-0.34%)
NSE Sep 15, 2025 15:31 PM
Volume: 108.7K
 

1310.30
-0.34%
Karvy
The company expects to receive the clearance certificate for its Ratlam facility from WHO within the next 10-15 days. Supply is expected to resume within 2 weeks time. Ipca has done around Rs 400 mn revenues till August 2015 and is hopeful of Rs 700 mn business this quarter. It is hopeful that the company should do Rs 1-1.2 bn business in quarters ahead. In FY 16E, the company should close the year with Rs 3.5 bn business.
Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended